Article Details
Retrieved on: 2022-06-10 22:39:57
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
To accomplish this, Senti Bio is building a synthetic biology platform that may enable the company to program next-generation cell and gene ...
Article found on: www.goodwinlaw.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here